Cargando…

Dahuang Zexie Decoction Protects against High-Fat Diet-Induced NAFLD by Modulating Gut Microbiota-Mediated Toll-Like Receptor 4 Signaling Activation and Loss of Intestinal Barrier

Increasing evidence suggests that intestinal dysbiosis, intestinal barrier dysfunction, and activated Toll-like receptor 4 (TLR4) signaling play key roles in the pathogenesis of NAFLD. Dahuang Zexie Decoction (DZD) has been verified to be effective for treating NAFLD, but the mechanisms remain uncle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Jing, Sun, Xiaoqi, Xue, Boyu, Fang, Nanyuan, Zhou, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702401/ https://www.ncbi.nlm.nih.gov/pubmed/29259643 http://dx.doi.org/10.1155/2017/2945803

Ejemplares similares

The Network Pharmacology Study of Dahuang Fuzi Decoction for Treating Incomplete Intestinal Obstruction
por: Guo, Jun-feng, et al.
Publicado: (2022)

Multi-Omics Integration Analysis Identifies Lipid Disorder of a Non-Alcoholic Fatty Liver Disease (NAFLD) Mouse Model Improved by Zexie–Baizhu Decoction
por: Cao, Yuhan, et al.
Publicado: (2022)

Effect of Dahuang Danpi Decoction on Lactobacillus bulgaricus growth and metabolism: In vitro study
por: Li, Chaoqun, et al.
Publicado: (2019)

Dahuang Danshen Decoction Inhibits Pancreatic Fibrosis by Regulating Oxidative Stress and Endoplasmic Reticulum Stress
por: Liang, Xiaoqiang, et al.
Publicado: (2021)

Dahuang Fuzi Baijiang decoction restricts progenitor to terminally exhausted T cell differentiation in colorectal cancer
por: Xu, Yihua, et al.
Publicado: (2022)

Network Pharmacology and In Vivo Analysis of Dahuang-Huangqi Decoction Effectiveness in Alleviating Renal Interstitial Fibrosis
por: Luo, Yan, et al.
Publicado: (2022)

Qualitative Analysis of Drug-Containing Plasma and its Application to Quantitative Analysis and Pharmacokinetic Study of Zexie Decoction Using UPLC-MS/MS
por: Wu, Jiashuo, et al.
Publicado: (2022)

Dahuang Fuzi Decoction Attenuates Renal Fibrosis and Ameliorates Mitochondrial Dysfunction in Chronic Aristolochic Acid Nephropathy
por: Shui, Guang-xing, et al.
Publicado: (2017)

Exploring anti-acute kidney injury mechanism of Dahuang-Gancao decoction by network pharmacology and experimental validation
por: Wang, Rui, et al.
Publicado: (2023)

Interleukin-17 Weakens the NAFLD/NASH Process by Facilitating Intestinal Barrier Restoration Depending on the Gut Microbiota
por: He, Shuying, et al.
Publicado: (2022)

Effect of Sheng-Jiang Powder on Gut Microbiota in High-Fat Diet-Induced NAFLD
por: Li, Juan, et al.
Publicado: (2020)

Integrating Network Pharmacology and RT-qPCR Analysis to Investigate the Mechanisms Underlying ZeXie Decoction-Mediated Treatment of Non-alcoholic Fatty Liver Disease
por: Wu, Jiashuo, et al.
Publicado: (2021)

Evaluation of the safety and efficacy of a Fuling-Zexie decoction for people with asymptomatic hyperuricemia: protocol for a prospective, double-blinded, randomized, placebo-controlled clinical trial
por: Yan, Jingyao, et al.
Publicado: (2022)

Gut Microbiota and Lifestyle Interventions in NAFLD
por: Houghton, David, et al.
Publicado: (2016)

Gegen Qinlian decoction enhances immunity and protects intestinal barrier function in colorectal cancer patients via gut microbiota
por: Li, Yang, et al.
Publicado: (2020)

Zi Qi Decoction Alleviates Liver Fibrosis by Inhibiting the Toll-Like Receptor 4 (TLR4)-Related Nuclear Factor kappa b (NF-κB) and Mitogen-Activated Protein Kinase (MAPK) Signaling Pathways
por: Zhou, Jingwen, et al.
Publicado: (2021)

Gegen Qinlian Decoction Attenuates High-Fat Diet-Induced Steatohepatitis in Rats via Gut Microbiota
por: Guo, Yi, et al.
Publicado: (2018)

Lingguizhugan Decoction Targets Intestinal Microbiota and Metabolites to Reduce Insulin Resistance in High-Fat Diet Rats
por: Ning, Ying, et al.
Publicado: (2022)

Gut Microbiota: Association with NAFLD and Metabolic Disturbances
por: Lau, E., et al.
Publicado: (2015)

Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
por: Jiang, Xiaofan, et al.
Publicado: (2020)

Intestinal Barrier and Permeability in Health, Obesity and NAFLD
por: Portincasa, Piero, et al.
Publicado: (2021)

Genetic diversity and population structure of Rheum tanguticum (Dahuang) in China
por: Zhang, Xiaoqin, et al.
Publicado: (2014)

Clinical antitumor application and pharmacological mechanisms of Dahuang Zhechong Pill
por: Tian, Yingying, et al.
Publicado: (2023)

Protective Effect of Danshen Zexie Decoction Against Non-Alcoholic Fatty Liver Disease Through Inhibition of ROS/NLRP3/IL-1β Pathway by Nrf2 Signaling Activation
por: Biao, Yaning, et al.
Publicado: (2022)

Leaky Gut in IBD: Intestinal Barrier–Gut Microbiota Interaction
por: Yu, Shunying, et al.
Publicado: (2022)

Maternal Betaine Supplementation Mitigates Maternal High Fat Diet-Induced NAFLD in Offspring Mice through Gut Microbiota
por: Sun, Liuqiao, et al.
Publicado: (2023)

Nostoc sphaeroids Kütz ameliorates hyperlipidemia and maintains the intestinal barrier and gut microbiota composition of high‐fat diet mice
por: Wei, Fenfen, et al.
Publicado: (2020)

Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
por: Chen, Jiezhong, et al.
Publicado: (2020)

Nutritional Approach Targeting Gut Microbiota in NAFLD—To Date
por: Moszak, Małgorzata, et al.
Publicado: (2021)

Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions
por: Hrncir, Tomas, et al.
Publicado: (2021)

Acupuncture improved hepatic steatosis in HFD-induced NAFLD rats by regulating intestinal microbiota
por: Wang, Haiying, et al.
Publicado: (2023)

Integrated Network Pharmacology and Gut Microbiota Study on the Mechanism of Huangqin Decoction in Treatment Diabetic Enteritis
por: Xu, Xiaomin, et al.
Publicado: (2022)

Treatment of Modified Dahuang Fuzi Decoction on Cognitive Impairment Induced by Chronic Kidney Disease through Regulating AhR/NF-κB/JNK Signal Pathway
por: Gu, Mingjia, et al.
Publicado: (2022)

Efficacy and Safety of Dahuang Zhechong Pill in Silicosis: A Randomized Controlled Trial
por: Tang, Wu-Yi-Nuo, et al.
Publicado: (2021)

CONSORT-Characteristics and metabolic phenotype of gut microbiota in NAFLD patients
por: Ge, Haize, et al.
Publicado: (2022)

The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2016)

The Association Between Gut Microbiota, Toll-Like Receptors, and Colorectal Cancer
por: Fang, Yongkun, et al.
Publicado: (2022)

Intestinal homeostasis and inflammation: Gut microbiota at the crossroads of pancreas–intestinal barrier axis
por: Zhang, Zhongwei, et al.
Publicado: (2022)

Role of gut microbiota on intestinal barrier function in acute pancreatitis
por: Li, Xue-Yang, et al.
Publicado: (2020)

Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis via gut microbiota
por: Liu, Meng-Ting, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b6i3jnidrsq4krs48t80locjmd